Currently, there are 1.15B common shares owned by the public and among those 1.14B shares have been available to trade.
The company’s stock has a 5-day price change of 4.92% and 17.03% over the past three months. NEM shares are trading 23.68% year to date (YTD), with the 12-month market performance up to 32.41% higher. It has a 12-month low price of $29.42 and touched a high of $50.72 over the same period. NEM has an average intraday trading volume of 7.78 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.73%, 13.16%, and 29.48% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Newmont Corp (NYSE: NEM) shares accounts for 73.83% of the company’s 1.15B shares outstanding.
It has a market capitalization of $58.74B and a beta (3y monthly) value of 0.51. The earnings-per-share (ttm) stands at -$2.14. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.40% over the week and 2.91% over the month.
Earnings per share for the fiscal year are expected to increase by 84.31%, and 23.72% over the next financial year.
Looking at the support for the NEM, a number of firms have released research notes about the stock. Scotiabank stated their Sector Outperform rating for the stock in a research note on Aug-20-24, with the firm’s price target at $48-$59. CIBC coverage for the Newmont Corp (NEM) stock in a research note released on July 10, 2024 offered a Sector Outperform rating with a price target of $61. JP Morgan was of a view on July 08, 2024 that the stock is Neutral, while UBS gave the stock Buy rating on June 17, 2024, issuing a price target of $40- $50. Jefferies on their part issued Buy rating on February 29, 2024.
